Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chankrit Sethi"'
Autor:
Stergios Zacharoulis, Luca Szalontay, Travis CreveCoeur, Justin Neira, Dominique Higgins, Zachary Englander, Eleonora Spinazzi, Chankrit Sethi, Peter Canoll, James Garvin, Rebecca Zylber, Steve Damment, Dmitry Zamoryakhin, Alexis Maddocks, Neil Feldstein, Jeffrey Bruce
Publikováno v:
Neuro-Oncology. 24:i35-i35
Histone deacetylase inhibitors have been found preclinically to be among the most active agents against DMGs, however, they are clinically ineffective with systemic delivery due to blood brain barrier limitations and toxicity. Using a repurposed devi
Autor:
Peter A. Sims, Luca Szalontay, Bradley Gampel, Stergios Zacharoulis, Peter Canoll, James Garvin, Eileen Stark, Chankrit Sethi, Wenting Zhao
Publikováno v:
Neuro-Oncology
Children with relapsed brain tumors are less responsive to treatment. These children often receive therapies without having any robust predictive method of potential benefit. Acute slice culturing(ASC) is a methodology permitting freshly operated tum
Autor:
Dominic Higgins, Alexis B. Maddocks, James Garvin, Rebecca J. Zylber, Jeffrey N. Bruce, Peter Canoll, Neil A. Feldstein, Eileen Stark, Chankrit Sethi, Stergios Zacharoulis, Zachary K. Englander, Steve Dammnett, Craig Cook, ZhenZhen Jin, Luca Szalontay
Publikováno v:
Neuro-Oncology
Convection-enhanced delivery (CED, the infusion of drugs under controlled pressure to the brain parenchyma via targeted micro-catheters, allows accurate anatomical targeting and delivery of higher (therapeutic) drug concentrations through clinically
Publikováno v:
Neuro-Oncology
Diffuse intrinsic pontine glioma (DIPG) remains a fatal disease with no effective drugs to date. Mutation-based precision oncology approaches are limited by lack of targetable mutations and genetic heterogeneity. We leveraged systems biology methodol
Autor:
Smit Patel, Uvesh Mansuri, Neel Patel, Purav Patel, Ronak Soni, Rupak Desai, Mohit Pahuja, Vinshi Khan, Chankrit Sethi
Publikováno v:
Journal of the American College of Cardiology. 69:424
Background: Atrial fibrillation (AFib) accounts for high rates of unfavorable outcomes in cardiac as well as non-cardiac patients. The unplanned 30-day readmission rate, cost burden and predictors in AFib patients treated with or without Endovascular